Work

Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India

Year: 2019

Type: article

Source: Pulmonary Pharmacology & Therapeutics

DOI: 10.1016/j.pupt.2019.101869

Authors: Aloke Ghoshal, Pradyut Waghray, George Dsouza, Mahip Saluja, Mayank Agarwal, Ashish Goyal, Sneha Limaye, Akash Balki, Sudhir Bhatnagar, Manish Jain, Sharad Tikkiwal, Abhijit Vaidya, Meena Lopez, Rashmi Hegde, Jaideep Gogtay

Institutions: National Allergy Asthma Bronchitis Institute, St.John's Medical College Hospital, Subharti Medical College, Chest Research Foundation, Cipla (India)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cipla

OpenAlex ID: W2992508676

FWCI: 1.056

Cites: 47

Cited by: 7

Related to: 10